The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2014
Made: 10th December 2014
Coming into force in accordance with article 1
At the Court at Buckingham Palace, the 10th day of December 2014Present,The Queen’s Most Excellent Majesty in Council
Accordingly, Her Majesty, in exercise of the powers conferred upon Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
Citation and commencement
1
This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) (No. 2) Order2014 and comes into force on the twenty-eighth day after the day on which it is made.
Amendments to the Misuse of Drugs Act 1971
2
The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.
3
In paragraph 1(a) of Part 1 (which specifies the drugs which are subject to control under that Act as Class A drugs)—
- (a) after “Trimeperidine” insert—
(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52).
- (b) after “4-Cyano-1-methyl-4-phenyl-piperidine” insert—
3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921); (6aR,9R) R,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD); (6aR,9R) R,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD); (6aR,9R) R,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD).
- (c) after “N,N-Diethyltryptamine” insert—
2,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone (LSZ).
4
For paragraph 1(b) of Part 1, substitute—
(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say— (i) by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; (iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents; (iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent;
Signed
Richard Tilbrook — Clerk of the Privy Council
Explanatory note
(This note is not part of the Order)
EXPLANATORY NOTE
This Order brings certain drugs under the control of the Misuse of Drugs Act 1971 (‘the Act’). Articles 3 and 4 of this Order bring a synthetic opiate, known as AH-7921, various tryptamines and LSD related compounds, as listed in the Order, under permanent control as Class A drugs under the Act.
Footnotes
[^f00001]: 1971 c. 38. Schedule 2 has been amended by section 21 of the Drugs Act 2005 (c. 17) and S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589, 1995/1966, 1996/1300, 1998/750, 2001/3932, 2003/1243, 2003/3201, 2005/3178, 2006/3331, 2008/3130, 2009/3209, 2010/1207, 2010/1833, 2011/744, 2012/1390, 2013/239, 2014/1106 and 2014/1352.
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.